The NLRP3 inflammasome is activated by nanoparticles through ATP, ADP and adenosine

Cell Death and Disease

Volumn 6, Issue , 2015, Pages

  Baron, L ^a   Gombault, A ^a   Fanny, M ^a   Villeret, B ^a   Savigny, F ^a   Guillou, N ^a   Panek, C ^a   Le Bert, M ^a   Lagente, V ^a   Rassendren, F ^a   Riteau, N ^b   Couillin, I ^c  

^a UNIVERSITÉ D'ORLÉANS   (France)

^b UNIVERSITÉ DE RENNES 1   (France)

^c INSTITUT DE GÉNOMIQUE FONCTIONNELLE   (France)

Author keywords

[No Author keywords available]

Indexed keywords

A2 A RECEPTOR; A2 B RECEPTOR; ADENOSINE 5' (N ETHYLCARBOXAMIDE); ADENOSINE DEAMINASE; ADENOSINE DIPHOSPHATE; ADENOSINE KINASE; ADENOSINE RECEPTOR; ADENOSINE TRIPHOSPHATE; ADENYLATE CYCLASE; BETA,GAMMA DIBROMOMETHYLENE 6 N,N DIETHYLADENOSINE TRIPHOSPHATE; CARBENOXOLONE; CRYOPYRIN; EQUILIBRATIVE NUCLEOSIDE TRANSPORTER 2; FLUFENAMIC ACID; GAP JUNCTION PROTEIN; INTERLEUKIN 1BETA; NANOPARTICLE; NITROBENZYLTHIOINOSINE; NUCLEOTIDE TRANSPORTER; PANNEXIN; PROTEIN; PURINERGIC P2X7 RECEPTOR; PURINERGIC P2Y1 RECEPTOR; PURINERGIC P2Y12 RECEPTOR; PURINERGIC P2Y2 RECEPTOR; PURINERGIC P2Y6 RECEPTOR; RECEPTOR; SHORT HAIRPIN RNA; SILICON DIOXIDE; TITANIUM DIOXIDE; UNCLASSIFIED DRUG; ADENOSINE; CARRIER PROTEIN; CYCLIC AMP; INFLAMMASOME; INOSITOL 3-PHOSPHATE; INOSITOL PHOSPHATE; NERVE PROTEIN; NLRP3 PROTEIN, HUMAN; PHOSPHOLIPASE C; PURINERGIC P2Y RECEPTOR; TITANIUM;

ANIMAL CELL; APOPTOSIS; ARTICLE; BONE MARROW DERIVED MACROPHAGE; CYTOKINE RELEASE; DOWN REGULATION; HUMAN; HUMAN CELL; HYDROLYSIS; IN VITRO STUDY; LUNG INJURY; MACROPHAGE; MOUSE; NEUTROPHIL; NONHUMAN; PNEUMONIA; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; SIGNAL TRANSDUCTION; WESTERN BLOTTING; ANIMAL; BIOLOGICAL MODEL; C57BL MOUSE; CELL LINE; CHEMISTRY; DRUG EFFECTS; METABOLISM; PATHOLOGY; SECRETION (PROCESS);

ADENOSINE; ADENOSINE DIPHOSPHATE; ADENOSINE TRIPHOSPHATE; ADENYLATE CYCLASE; ANIMALS; CARRIER PROTEINS; CELL LINE; CONNEXINS; CYCLIC AMP; HUMANS; INFLAMMASOMES; INOSITOL PHOSPHATES; INTERLEUKIN-1BETA; MACROPHAGES; MICE, INBRED C57BL; MODELS, BIOLOGICAL; NANOPARTICLES; NERVE TISSUE PROTEINS; PNEUMONIA; RECEPTORS, PURINERGIC P1; RECEPTORS, PURINERGIC P2Y; SIGNAL TRANSDUCTION; SILICON DIOXIDE; TITANIUM; TYPE C PHOSPHOLIPASES;

EID: 84923206530     PISSN: None     EISSN: 20414889     Source Type: Journal    
DOI: 10.1038/cddis.2014.576     Document Type: Article

References (36)

1. Yazdi AS, Drexler SK, Tschopp J. The role of the inflammasome in nonmyeloid cells. J Clin Immunol 2010; 30: 623-627.
2. Dostert C, Meylan E, Tschopp J. Intracellular pattern-recognition receptors. Adv Drug Deliv Rev 2008; 60: 830-840.
3. Antonioli L, Pacher P, Vizi ES, Hasko G. CD39 and CD73 in immunity and inflammation. Trends Mol Med 2013; 19: 355-367.
4. Eltzschig HK, Sitkovsky MV, Robson SC. Purinergic signaling during inflammation. N Engl J Med 2012; 367: 2322-2333.
5. Jacobson KA, Balasubramanian R, Deflorian F, Gao ZG. G protein-coupled adenosine (P1) and P2Y receptors: ligand design and receptor interactions. Purinergic Signal 2012; 8: 419-436.
6. Baldwin SA, Beal PR, Yao SY, King AE, Cass CE, Young JD. The equilibrative nucleoside transporter family, SLC29. Pflugers Arch 2004; 447: 735-743.
7. Young JD, Yao SY, Baldwin JM, Cass CE, Baldwin SA. The human concentrative and equilibrative nucleoside transporter families, SLC28 and SLC29. Mol Aspects Med 2013; 34: 529-547.
8. Chen JF, Eltzschig HK, Fredholm BB. Adenosine receptors as drug targets-what are the challenges? Nat Rev Drug Discov 2013; 12: 265-286.
9. Eckle T, Fullbier L, Wehrmann M, Khoury J, Mittelbronn M, Ibla J et al. Identification of ectonucleotidases CD39 and CD73 in innate protection during acute lung injury. J Immunol 2007; 178: 8127-8137.
10. Karmouty-Quintana H, Xia Y, Blackburn MR. Adenosine signaling during acute and chronic disease states. J Mol Med (Berl) 2013; 91: 173-181.
11. Huszar E, Vass G, Vizi E, Csoma Z, Barat E, Molnar Vilagos G et al. Adenosine in exhaled breath condensate in healthy volunteers and in patients with asthma. Eur Respir J 2002; 20: 1393-1398.
12. Esther CR Jr., Lazaar AL, Bordonali E, Qaqish B, Boucher RC. Elevated airway purines in COPD. Chest 2011; 140: 954-960.
13. Goodarzi MT, Abdi M, Tavilani H, Nadi E, Rashidi M. Adenosine deaminase activity in COPD patients and healthy subjects. Iran J Allergy Asthma Immunol 2010; 9: 7-12.
14. Chunn JL, Molina JG, Mi T, Xia Y, Kellems RE, Blackburn MR. Adenosine-dependent pulmonary fibrosis in adenosine deaminase-deficient mice. J Immunol 2005; 175: 1937-1946.
15. Sun CX, Zhong H, Mohsenin A, Morschl E, Chunn JL, Molina JG et al. Role of A2B adenosine receptor signaling in adenosine-dependent pulmonary inflammation and injury. J Clin Invest 2006; 116: 2173-2182.
16. Zaynagetdinov R, Ryzhov S, Goldstein AE, Yin H, Novitskiy SV, Goleniewska K et al. Attenuation of chronic pulmonary inflammation in A2B adenosine receptor knockout mice. Am J Respir Cell Mol Biol 2010; 42: 564-571.
17. Aldrich MB, Blackburn MR, Datta SK, Kellems RE. Adenosine deaminase-deficient mice: models for the study of lymphocyte development and adenosine signaling. Adv Exp Med Biol 2000; 486: 57-63.
18. Sun CX, Young HW, Molina JG, Volmer JB, Schnermann J, Blackburn MR. A protective role for the A1 adenosine receptor in adenosine-dependent pulmonary injury. J Clin Invest 2005; 115: 35-43.
19. Joseph SM, Buchakjian MR, Dubyak GR. Colocalization of ATP release sites and ecto- ATPase activity at the extracellular surface of human astrocytes. J Biol Chem 2003; 278: 23331-23342.
20. Harris AL. Connexin channel permeability to cytoplasmic molecules. Prog Biophys Mol Biol 2007; 94: 120-143.
21. Orellana JA, Froger N, Ezan P, Jiang JX, Bennett MV, Naus CC et al. ATP and glutamate released via astroglial connexin 43 hemichannels mediate neuronal death through activation of pannexin 1 hemichannels. J Neurochem 2011; 118: 826-840.
22. Cohen HB, Briggs KT, Marino JP, Ravid K, Robson SC, Mosser DM. TLR stimulation initiates a CD39-based autoregulatory mechanism that limits macrophage inflammatory responses. Blood 2013; 122: 1935-1945.
23. Chen Y, Corriden R, Inoue Y, Yip L, Hashiguchi N, Zinkernagel A et al. ATP release guides neutrophil chemotaxis via P2Y2 and A3 receptors. Science 2006; 314: 1792-1795.
24. Sun L, Ye RD. Role of G protein-coupled receptors in inflammation. Acta Pharmacol Sin 2012; 33: 342-350.
25. 2+ and cAMP. Nature 2012; 492: 123-127.
26. Nordenhall C, Pourazar J, Blomberg A, Levin JO, Sandstrom T, Adelroth E. Airway inflammation following exposure to diesel exhaust: a study of time kinetics using induced sputum. Eur Respir J 2000; 15: 1046-1051.
27. Ouyang X, Ghani A, Malik A, Wilder T, Colegio OR, Flavell RA et al. Adenosine is required for sustained inflammasome activation via the A(2)A receptor and the HIF-1alpha pathway. Nat Commun 2013; 4: 2909.
28. Li S, Li X, Guo H, Liu S, Huang H, Liu N et al. Intracellular ATP concentration contributes to the cytotoxic and cytoprotective effects of adenosine. PLoS One 2013; 8: e76731.
29. Baroja-Mazo A, Martin-Sanchez F, Gomez AI, Martinez CM, Amores-Iniesta J, Compan V et al. The NLRP3 inflammasome is released as a particulate danger signal that amplifies the inflammatory response. Nat Immunol 2014; 15: 738-748.
30. Lu Q, Newton J, Hsiao V, Shamirian P, Blackburn MR, Pedroza M. Sustained adenosine exposure causes lung endothelial barrier dysfunction via nucleoside transporter-mediated signaling. Am J Respir Cell Mol Biol 2012; 47: 604-613.
31. Hussain S, Vanoirbeek JA, Luyts K, De Vooght V, Verbeken E, Thomassen LC et al. Lung exposure to nanoparticles modulates an asthmatic response in a mouse model. Eur Respir J 2011; 37: 299-309.
32. Raghunathan VK, Devey M, Hawkins S, Hails L, Davis SA, Mann S et al. Influence of particle size and reactive oxygen species on cobalt chrome nanoparticle-mediated genotoxicity. Biomaterials 2013; 34: 3559-3570.
33. Bhabra G, Sood A, Fisher B, Cartwright L, Saunders M, Evans WH et al. Nanoparticles can cause DNA damage across a cellular barrier. Nat Nanotechnol 2009; 4: 876-883.
34. Couillin I, Vasseur V, Charron S, Gasse P, Tavernier M, Guillet J et al. IL-1R1/MyD88 signaling is critical for elastase-induced lung inflammation and emphysema. J Immunol 2009; 183: 8195-8202.
35. Gasse P, Mary C, Guenon I, Noulin N, Charron S, Schnyder-Candrian S et al. IL-1R1/MyD88 signaling and the inflammasome are essential in pulmonary inflammation and fibrosis in mice. J Clin Invest 2007; 117: 3786-3799.
36. Muller M, Eugster HP, Le Hir M, Shakhov A, Di Padova F, Maurer C et al. Correction or transfer of immunodeficiency due to TNF-LT alpha deletion by bone marrow transplantation. Mol Med 1996; 2: 247-255.